ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The War Room/DailyClout Pfizer Documents Analysis Volunteers Publish e-Book Available on DailyClout.io's Website

Palm Beach, Florida (Newsworthy.ai) Tuesday Jan 17, 2023 @ 1:30 PM Pacific —

A team of 3,500 medical experts from The War Room/DailyClout Pfizer Documents Analysis Project has helped expose the truth about Pfizer's COVID-19 mRNA drug, according to a new eBook.

The book is based on primary source Pfizer documents that were released under a court order by the U.S. Food and Drug Administration.

According to the book, Pfizer knew during the clinical trial that its COVID-19 mRNA drug was harmful on a large scale, could be shed from person to person, and even contributed to deaths. Despite this knowledge, Pfizer and the FDA, assisted by the CDC and mainstream media, suppressed this information and prevented people from being able to give informed consent to receive treatment.

"The Pfizer Reports eBook provides an extensive analysis of the primary source Pfizer clinical trial documents to the public. The reports show that Pfizer knew during the trial that its COVID-19 mRNA drug was harmful on a large scale, could be shed from person to person, and even contributed to deaths," said Amy Kelly, Project Manager of the Pfizer Document Investigations Team. "People who took this medication were not fully informed about its harms prior to receiving it, so one of the core tenets of medicine – informed consent for patients – was grossly violated."

"The groundbreaking new book sends shockwaves through Pfizer's criminal enterprise." writes The Vigilant Fox in a review of the ebook documents. Mr. Fox further states "Seventy-five years. That’s how long Pfizer and the FDA tried to hide the Pfizer documents from public view — long after just about everyone affected is dead. It wasn’t until renowned attorney Aaron Siri led a FOIA case against the FDA that a federal judge ordered the documents to be released in 108 days, the same amount of time it took the FDA to approve the Covid-19 injections.

Pfizer Document Investigations Team Project Manager Amy Kelly is available for interviews to discuss the book and the findings of the Pfizer Documents Analysis Project.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News at the speed of influence™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.